C. Diff clinical trials at UCSF

1 research study open to eligible people

C. diff stands for Clostridioides difficile, a bacterium that affects the gut. UCSF is testing fecal microbiota transplants on patients with this condition. Researchers log information on treatments to better understand outcomes for these infections.

Showing trials for

  • Fecal Microbiota Transplant National Registry

    open to all eligible people

    A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness

    San Francisco, California and other locations

Our lead scientists for C. Diff research studies include .

Last updated: